Alex Zhavoronkov· biogerontology·· 10 天前AI 评分18
英矽智能谈早期授权证据包
Early-stage licensing clears when partners can score a named target product profile against a full evidence package. Nikolaj Kulahin Roed...
AI 导读
当合作方能够对照完整证据包对具名目标产品概况进行评分时，早期授权即可通过。Nikolaj Kulahin Roed 在 #ARDD2026 上发言。照片：https://agingpharma.org/photos2026
来源：Alex Zhavoronkov · x.com